OncLive: PARP Inhibitors Are Under Study as Treatment Options Beyond BRCA-Mutated Breast Cancer

Dr. Virginia Kaklamani, Medicine/Mays Cancer Center, is quoted in this article. Dr. Marcela Mazo, Dr. Kate Lathrop and Dr. Heidi Ko, Medicine/Mays Cancer Center, are also mentioned.

 

Read More